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32nd Annual Canine Symposium
My Pet has Changed:
Understanding Aging-Related
Behavior Changes in Dogs
Dogs, like people, may experience dementia
as they age. Fortunately, explained Dr. Ilana
Reisner, assistant professor of behavioral medi-
cine and director of the behavior clinic at
VHUP, the behavior changes associated with
age-related degeneration – termed “cognitive
dysfunction syndrome” (CDS) – can be man-
aged through medication, and environmental
and behavioral modification. Dr. Reisner dis-
cussed the prevalence, pathogenesis, clinical
manifestations, diagnosis and treatment of
CDS.
The clinical signs of CDS result from a
number of degenerative changes, including the
death of brain cells secondary to oxidative
damage. This leads to subsequent cerebral and
cerebellar atrophy, and ventricular enlarge-
ment. The brain tissue is further compromised
by decreased local blood flow and deposition of
beta-amyloid protein. Mental capacity is physi-
ologically altered by neurotransmitter and
receptor dysfunction. “The brain pathology
impairs the way affected dogs think and func-
tion. This results in behavioral changes,” said
Dr. Reisner.
The signs of CDS, which was first recog-
nized in dogs about 10 years ago, include anxi-
ety; disorientation (i.e., apparent confusion
and memory loss, staring, aimless wandering,
getting “stuck” in corners); inappropriate elimi-
nation (i.e., “accidents” in housetrained dogs,
failure to adequately signal at the door, inap-
propriate elimination in view of owners,
indoor elimination shortly after being out-
doors); changes in social behavior (i.e., social
detachment, irritability, decreased interest in
interaction); changes in sleep-wake patterns
(i.e., evening restlessness, decreased nighttime
sleep, more frequent and deeper daytime
sleep); and changes in activity level (i.e.,
decreased activity or increased activity with
repetitive behaviors).
It is important to differentiate behavioral
problems associated with CDS from those of
other physical causes because, Dr. Reisner
explained, “in the elderly dog, we can see
behavioral changes that are manifestations of
physical problems.”
For example, decreased responsiveness, sim-
ilar to that of CDS, can be caused by the
expected sensory impairment of old age.
Impaired mobility can result from osteoarthri-
tis, cardiovascular disease and hormonal disor-
ders. Inappropriate elimination can be a symp-
tom of urinary tract or systemic disease, or of
neurological impairment.
Nevertheless, CDS is a significant problem,
particularly in light of the fact that there are
some 18 million pet dogs over seven years of
age in the U.S. In a recent prevalence study that
surveyed owners of 180 dogs between the ages
of 11 and 16, 28 percent of owners of 11-12-
year-old dogs, and 68 percent of owners of 15-
16-year-old dogs, reported one or more cate-
gories of cognitive impairment. In another
study, 75 percent of owners of older dogs
reported that their pets exhibited at least one
sign of CDS, yet only 12 percent of owners said
they had spoken to their veterinarian about it.
CDS is probably underreported by owners,
said Dr. Reisner, because “people sometimes
don’t complain about behavioral problems that
they view as normal and almost inevitable in
old dogs.”
Unfortunately, Dr. Reisner pointed out,
CDS worsens with age, hence the need for
timely diagnosis and treatment. A diagnosis of
CDS, which is based on clinical signs, cannot
be made until underlying medical causes for
the behavioral changes have been ruled out or
accounted for.
The choices for drug therapy for CDS are
varied and diverse. Perhaps the most widely-
touted is selegiline (Anipryl®), which enhances
dopamine function in the brain. In a recent
study of 200 dogs with CDS, selegiline admin-
istration significantly improved their activity
levels, sleep-wake cycles and elimination habits.
Other drug categories used in the treatment
of CDS include vasodilators, calcium-channel
blockers, antidepressants and sedatives. Antiox-
idants (vitamins E and C, selenium), which
scavenge free radicals and thereby reduce tissue
damage, have been used with some success. In
several studies, Hill’s Prescription Diet® b/d™ –
an antioxidant diet designed to reduce brain
tissue damage – was associated with improve-
ments in social interaction, discrimination tests
and activity level in cognitively-impaired older
dogs.
In dogs suffering from CDS, psychophar-
macology must be combined with environ-
mental modification. For example, said Dr.
Reisner, senescent dogs that are eliminating
indoors should be treated like pups: Restrict
access to indoor areas, do not rely on signaling
behavior, reward outdoor elimination and
modify feeding schedules.
In conclusion, she added, behavioral prob-
lems in elderly dogs rarely exist in isolation, so
any concurrent medical problems must be
diagnosed and treated. Behavioral changes
should be closely monitored, and veterinary
visits increased to every three or four months,
she stressed, because “our aged pets deserve our
full commitment and care.”
Chemotherapy for the Canine
Cancer Patient
Chemotherapy has served to expand both
the length and quality of life for dogs with can-
cer. Dr. Jennifer Baez, V’92, assistant professor
of oncology at VHUP, described the pathogen-
esis of cancer, and chemotherapy and other
treatment options in dogs.
Cancer, the manifestation of uncontrolled
cell growth, occurs as a result of genetic dam-
age and/or changes in a cell. Such changes can
be caused by innate genetic factors, as in the
case of certain cancer-prone breeds like boxers,
German shepherds, golden retrievers and Scot-
tish terriers. In these breeds, oncogenes – genes
that initiate the cancer process – have been
inadvertently selected for over time. Cancer can
also result from DNA damage by hormones
and carcinogens (chemical, physical, radiation,
foreign bodies, viruses). In healthy animals,
cells that are damaged undergo apoptosis, or
natural cell death. Cancer cells, however, have
lost this ability and therefore grow uncontrol-
lably. The course and rate of this growth is
determined by cancer tissue type (i.e., heman-
giosarcoma vs. thyroid carcinoma).
Cancer is a significant disease in dogs, said
The 32nd Annual Canine Symposium was
held on Saturday, January 26 at VHUP.
The event was generously supported by
Pedigree®. Six faculty members gave pre-
sentations on an array of medical prob-
lems in dogs
Following are summaries of the faculty
presentations:
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Dr. Baez. Nearly one-quarter of all dogs, and 45
percent of dogs older than ten years of age, will
die of cancer. The incidence of canine cancer
appears to be on the rise, which could be par-
tially accounted for by increased life span and
better diagnostic methods.
Treatment strategies for cancer in dogs dif-
fer somewhat from those employed in people.
In the latter, the goal is a cure, and very aggres-
sive regimens are often used, resulting in severe
side effects that may require intensive support-
ive care. In dogs, on the other hand, the goal of
therapy is to extend a good quality of life, so
treatments are generally less aggressive.
Treatment is based on histologic grade,
which determines tumor aggressiveness and
disease progression, or staging. Low-grade
tumors, which are slow to metastasize, general-
ly carry a good prognosis and are often treated
with radiation and/or surgery. High-grade
tumors, conversely, are fast to metastasize, and
are normally treated with chemotherapy
and/or surgery to prolong survival. Cancer is
staged using a variety of diagnostic tests, such
as blood work, radiography, ultrasound, CT
and MRI.
Surgery is most effective when a tumor is
low-grade and/or when it is localized with no
evidence of metastasis. Further, the tumor
should be in an area where there is enough skin
and tissue to secure adequate tissue margins.
Radiation, which damages and kills rapidly-
dividing cells, can be used as primary therapy
or to purge surgical margins of any remaining
tumor cells. Radiation works best in cancers
that are sensitive to it, when metastasis has not
yet occurred, and when tumor location is not
proximate to tissue that, if damaged by radia-
tion, could be life-threatening for the patient.
Chemotherapy is employed when cancer is
present in multiple locations. It is most effec-
tive for cancers that are sensitive to chemother-
apy, in cases where only microscopic disease is
present, and in patients that are otherwise
healthy and feeling good. Chemotherapy works
at different stages of the cell cycle to halt repli-
cation of rapidly-dividing cells, which includes
cancer cells. Many classes of chemotherapy
exist, each working by a slightly different
mechanism.
Chemotherapy can be used as a primary
agent, such as for lymphoma, or as an initial
treatment to shrink a tumor prior to surgery or
radiation. Chemotherapeutic agents can be
administered systemically, intralesionally, via
inhalation or intracavitarily. Many new
chemotherapeutic agents are available or under
investigation for use in animals.
Resistance to chemotherapy is the most
common cause for treatment failure, as cancer
cells can develop mechanisms for excreting or
inactivating the drug. Chemotherapy delivers
the bad with the good, as it damages other rap-
idly-dividing cells like bone marrow, intestinal
and, occasionally, hair cells. Side effects of
chemotherapy include low white blood cell
counts, vomiting, diarrhea, and hair loss. But,
Dr. Baez said, “Our canine patients are amaz-
ingly tolerant of the procedure.”
A fourth, newer, treatment modality exists
for the treatment of cancer in dogs: biotherapy,
which includes immunotherapy, angiogenesis
inhibition and growth factor modulation. Bio-
therapy, Dr. Baez declared, is where the future
of veterinary oncology likely lies. However, she
added, “Because cancer is so multifocal and
complex, there is never going to be a single
magic bullet to cure cancer.”
Interventional Radiology – 
a New Tool for Difficult Cases
An established tool in human medicine,
interventional radiology has tremendous
potential for the treatment of serious maladies
in pets. Dr. Chick Weisse, V’98, resident in sur-
gery at VHUP, described several interventional
radiology procedures and their potential appli-
cations in a variety of serious medical condi-
tions in dogs. “These techniques have revolu-
tionized disease treatment in human
medicine,” Dr. Weisse said of interventional
radiology procedures, “and now we’re looking
at their potential applications in veterinary
medicine.” He is working closely with Dr. Jeff
Solomon, an interventional radiologist at the
Hospital of the University of Pennsylvania,
who donates his time and expertise.
Interventional radiology utilizes fluoroscopy
to visualize the placement of catheters, stents,
balloons, and coils into blood vessels and other
tubular structures. These procedures are still
largely experimental in animals. As a diagnostic
and treatment modality, interventional radiolo-
gy has many potential advantages over conven-
tional techniques like surgery: minimal inva-
siveness, minimal anesthesia time, decreased
morbidity/mortality, reduced hospital stay and
lower cost. Interventional radiology is under
investigation at VHUP for many different
applications in animals.
Dr. Weisse presented the case of “Prince”,
the Yorkshire terrier, whose respiratory distress
was incited by degeneration of his tracheal car-
tilages. Interventional radiology was successful-
ly employed to place a stent to keep the trachea
open.
In large-breed dogs prone to intrahepatic
portosystemic shunts, it is a debilitating condi-
tion in which a shunt carries non-detoxified
blood from the portal supply directly into the
systemic circulation. Affected dogs suffer neu-
rologic conditions such as seizures and head
pressing as well as urolithiasis and stunted
growth. Surgery for this condition carries a
reported 15%-66% percent mortality rate.
Under fluoroscopy, a contrast agent is used to
aid in passing a catheter into the shunting ves-
sel. Thrombogenic coils are then passed into
the shunt to occlude blood flow and return the
circulation to normal.
Embolization can be used to obstruct blood
supply to tumors, reduce hemorrhage, and
provide pain relief. Currently performed to
shrink uterine fibroids in women as an alterna-
tive to hysterectomy, embolization would be
particularly useful in animals with fibroids or
other tumors that are so invasive as to render
surgery ineffective.
For malignant tumors, a procedure called
chemoembolization can be performed to local-
ize drug concentrations to the desired site by
delivering chemotherapeutic agents directly
into the vessels feeding a tumor. Embolizing
particles are then deposited into these vessels,
thereby reducing blood supply to the tumor
and hampering the tumor’s ability to excrete
the drug. Dr. Weisse presented the case of
“Bobo” the cocker spaniel, who had a nonre-
sectable tumor eroding through the orbital
bone into the nasal cavity and skull.
Chemoembolization was delivered through a
catheter placed in the femoral artery and fed
up into the superficial temoporal artery in the
head. Three weeks later, the tumor was almost
undetectable. In another case, a dog with
osteosarcoma had one affected leg amputated.
When a second tumor later appeared, amputat-
ing the other affected leg was not an option. A
catheter was inserted into the femoral artery
and a microcatheter then fed into the circum-
flex humeral artery. After embolization was
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performed, an angiogram confirmed that the
blood supply to the tumor was successfully ter-
minated. A palliative rather than a curative
approach, chemoembolization may need to be
repeated if tumors grow back.
Interventional radiology is a safe alternative
to surgery for a variety of other procedures,
said Dr. Weisse. Angiograms can be used to
locate internal areas of hemorrhage, and
embolization can then be performed to control
bleeding. To dissolve blood clots, thrombolytic
drugs can be delivered to the thrombus site via
catheterization and fluoroscopy. Interventional
radiology can also provide less invasive means
for inserting nephrostomy and gastrostomy
tubes, and performing liver biopsies.
New Perspectives on
Osteoarthritis
Debilitating though osteoarthritis may be,
the disease occurrence and course can both be
influenced by environmental modulation. Dr.
Gail K. Smith, V’74, professor of orthopedic
surgery and chairman of the department of
clinical studies at VHUP, discussed the patho-
genesis of hip dysplasia and subsequent
osteoarthritis, and presented a yet-unpub-
lished, landmark study conducted at Nestle-
Purina that clearly demonstrated an association
between dietary regulation and development of
joint disease.
Hip dysplasia, which was first described in
1935, is a condition in which the femoral head
(“ball”) does not fit tightly into the pelvic
acetabulum (“socket”). Excess wear develops in
the joint, leading to synovial membrane
inflammation, cartilage damage, subchondral
bone sclerosis, and formation of bony prolifer-
ations called osteophytes. Osteoarthritis can
occur in other joints as well, and is a significant
source of discomfort.
“We care about osteoarthritis because it
causes pain and disability in dogs and in peo-
ple,” Dr. Smith explained.
Hip dysplasia is a polygenic trait and there-
fore very complex. The breeding community
has taken great efforts to reduce the incidence
of the disease through careful breeding. How-
ever, said Dr. Smith, in spite of these efforts,
they have not been very successful. In a preva-
lence study reviewing Orthopedic Foundation
for Animals (OFA) figures from 1981-1988, 21
percent of surveyed German shepherds had hip
dysplasia. During the subsequent eight years,
that figure was 23 percent. Likewise, the occur-
rence rates for Rottweilers, and Labrador and
golden retrievers – which hovered in the range
of 24 percent – did not significantly fall over
time, as might have been expected if selective
breeding were effective. In a study of Airedale
terriers in Berlin, the prevalence rates of hip
dysplasia in 1981, 1991 and 1996 were 45, 50
and 45 percent, respectively. A Finnish study of
10,335 German shepherds between 1981 and
1997 also showed no genetic headway in reduc-
ing the occurrence of hip dysplasia.
“Genetically, we’re not getting anywhere
fast,” Dr. Smith concluded. “But can we do
things environmentally? The answer is yes.”
Limiting the forces on a joint that is geneti-
cally predisposed to hip dysplasia and/or
osteoarthritis can reduce the occurrence and
severity of disease, he said. Several studies in
the past have shown that restricting weight
gain, growth rate and exercise can produce
small decreases in the occurrence of degenera-
tive joint disease.
Our understanding of hip dysplasia may be
revolutionized by a longitudinal study con-
ducted at Nestle-Purina for which Dr. Smith
was a coinvestigator. It demonstrated for the
first time that limiting a dog’s intake of com-
mercial dog food throughout its life signifi-
cantly reduces the occurrence and severity of
hip laxity and/or osteoarthritis. The study,
which has not yet been published, tracked 24
paired littermates of Labrador retrievers main-
tained at Nestle-Purina for 14 years. For each
pair of dogs, one was fed ad libitum for 15
minutes daily, while the other (“limit-fed”) dog
was fed 75 percent of the quantity the first dog
consumed. To increase the reliability of the
results, the hips were uniformly scored using
several different diagnostic methods.
At two years of age, 16 of the dogs fed ad
libitum, and only seven of the leaner, limit-fed
dogs, had hip dysplasia. Other joints were
affected by diet as well: At eight years of age, 19
dogs in the ad-libitum group, and 12 dogs in
the limit-fed group, had osteoarthritis of the
shoulder. In fact, 68 percent of the ad-libitum
dogs and ten percent of limit-fed dogs had
both hip and shoulder affected, and 77 percent
of the ad-libitum dogs and ten percent of the
limit-fed dogs were affected in any two joints.
Clearly dietary restriction has a protective
effect on other joints as well.
The study also demonstrated that the inci-
dence of hip dysplasia increases linearly with
age such that normal hip conformation at two
years of age is not necessarily predictive of hip
dysplasia risk in later years: About half of the
dogs with normal hips at two years of age
became dysplastic later in life. The study con-
cluded that for dogs kept lean there was a 6:1
reduction in hip osteoarthritis by two years of
age and a 2:1 reduction by end of life. The
study also showed that leaner dogs that experi-
ence hip dysplasia generally have a lower sever-
ity of the condition, and dysplastic dogs that
are kept lean maintain better use of their limbs,
require less pain medication… and have a bet-
ter quality of life.
Canine Eye Diseases and their
Treatment 
A dog’s eyesight is subject to a variety of
potential problems. Dr. Elaine Holt, lecturer in
ophthalmology at VHUP, discussed several com-
mon inherited ophthalmic conditions in dogs.
Dogs’ vision differs somewhat from that of
people because of unique architectural features
of the canine eye. Dogs have fewer cones – the
photoreceptors for color vision, and so cannot
perceive color as well as people can. Dogs’ eyes
are adapted to seeing light and movement. The
canine retina is comprised primarily of rods,
the photoreceptors that detect dim light and
movement. They also have a reflective layer
called the tapetum lucidum, which appears as
iridescent green. It is thought that this reflective
layer “allows the retina to get sort of a double
exposure of light back to the eye,” Dr. Holt
explained.
Progressive retinal atrophy (PRA) is a
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including the cocker spaniel, Irish setter,
Labrador retriever and miniature schnauzer. A
disease of the rod photoreceptors, PRA typically
presents as loss of night vision and usually pro-
gresses to complete blindness. An irreversible
condition for which there is no treatment, PRA
can be diagnosed by fundic exam, electroretino-
gram and, in some breeds, genetic testing.
Vision loss in dogs can also be caused by
glaucoma, a disease of the optic nerve that usu-
ally presents in dogs as an elevation in intraoc-
ular pressure. Glaucoma usually results from
an anatomic or physiologic abnormality in the
drainage angle, rendering it unable to siphon
off fluid from the aqueous humor. Fluid then
builds up in the anterior chamber, causing the
eye to stretch. The disease, which usually affects
both eyes, irreversibly damages the retina and
optic nerve. Common in cocker spaniels, Basset
hounds and Chow Chows, acute glaucoma
presents with pain, ocular cloudiness/redness,
pupillary dilation and vision loss. Glaucoma is
diagnosed with either a Schiotz tonometer or a
Tonopen, handheld instruments used to meas-
ure intraocular pressure. Topical and systemic
drugs are available to decrease intraocular pres-
sure, but medication alone is rarely successful
over the long term. Surgical treatment –
cyclophotocoagulation – employs a laser to
destroy the aqueous-producing organ, the cil-
iary body. This is more often an eye-saving,
rather than a vision-saving, procedure. Alterna-
tively, enucleation can be performed to remove
the eye.
The most common cause of blindness in
dogs is cataracts, which are opacities in the lens
of the eye caused by irreversible alterations in
the lens metabolism, such as diabetes mellitus.
Not all cloudy lenses are cataracts, Dr. Holt
cautioned. Nuclear sclerosis, a normal old-age
change characterized by hardening of the lens,
can be mistakenly diagnosed as cataracts. Not
preventable or treatable with medication,
cataracts can be surgically removed by a
process called phacoemulsification: Ultrasound
is applied directly to the lens to shatter the lens
fibers, which are then aspirated out. Eighty per-
cent successful (complications like glaucoma
and retinal detachment occur in about one in
five cases), phacoemulsification returns func-
tional vision to the eye, but without an intra-
ocular lens implant the ability to focus is poor.
Keratoconjunctivitis sicca (KCS), “dry eye,”
is a common canine problem to which toy
breeds, like Lhasa apsos and shih tzus, are
prone. In cases of KCS, the lacrimal (tear)
glands are unable to produce adequate mois-
ture for the cornea. Signs of KCS include ocu-
lar redness and cloudiness, thick discharge and
recurrent eye infections. KCS is diagnosed with
the Schirmer tear test, which measures tear
production. Most affected dogs respond well to
medical treatment, which includes cyclosporine
– a tear stimulant, artificial tears, antibiotics
and anti-inflammatory drugs.
The eyelids can also be the source of ocular
problems, Dr. Holt added. Entropion – inver-
sion of the eyelid(s), occurs commonly in
wrinkled breeds like bulldogs, shar peis, Chow
Chows and Rottweilers. Entropion is damaging
to the eye because it allows the hair from the
face to rub against the surface of the eye, lead-
ing to excessive squinting, tear production and
corneal Ulcers. Entropion is repaired with sur-
gery to evert the affected eyelid(s).
Antibiotic Resistance:
Malice in Wonderland
Ever since Ehrlich reported in 1907 that
Trypanosoma brucei became resistant to para-
rosaniline after repeated exposure, we have had
a sense of the resistance faculties of bacteria.
Dr. Shelley Rankin, research assistant professor
in microbiology at the School, discussed the
unique mechanisms of bacterial resistance.
Bacteria are single-celled organisms with a
cell wall, cell membrane, single chromosome,
DNA fragments called plasmids, protein-pro-
ducing ribosomes and, in some cases, flagella
that provide motility. Plentiful and ubiquitous,
bacteria exist in greater quantity on a human
hand than people exist on the entire earth. And
no natural environment is too harsh for them –
from hot springs to Antarctic ice. Earth’s very
first inhabitants, bacteria are its true pioneers.
As such, they have developed sophisticated sur-
vival skills.
Dr. Rankin uses a single word to describe the
staying power of these hardy organisms: MAL-
ICE (Microorganisms Always Live In Challeng-
ing Environments). Perhaps their biggest envi-
ronmental challenge is each other, she said.
“They are competing for food sources. If they
can produce something that is going to kill their
neighbor, then they will get all of the food.”
Millions of years ago, soil bacteria developed
the genetic mechanisms to produce their own
antibiotics to fend off these hungry neighbors.
In turn, the neighbors developed resistance
mechanisms to allow them to survive these
assaults. This micro-armory consists of every-
thing from barriers to nets, pumps to explo-
sives. These sinister mechanisms have also ham-
pered man’s every attempts to use antibiotics.
Case in point: penicillin. The first penicillin
extract was produced in 1940. Within a year, a
substance was identified in in E. coli that could
inactivate penicillin. Sulphanilamide resistance
was also reported in Streptococcus. Subsequent-
ly, some bacteria were found to possess surface
modifications that decreased their permeability
to fluoroquinolones, others to modify their
binding sites in order to resist antibiotics like
rifampin and vancomycin. And still others were
found to have enzymes like beta lactamases that
could inactivate or modify certain antibiotics.
At one time, it was thought that a random
gene mutation produced an independent event
of resistance to one drug. Today, we know that
the acquisition of resistance involves more than
a simple mutation. Rather, it involves several
key players: R-plasmids, autonomous DNA ele-
ments, promote the transmission of resistance
mechanisms. Transposons are mobile DNA ele-
ments that can move genes to a plasmid for
later transmission to other bacteria. Integrons,
which are present on transposons, constantly
accept new genes, which further helps to build
the armory of drug resistance.
When we overuse antibiotics, Dr. Rankin
explained, we create an environment in which
the few bacteria that possess antibiotic resist-
ance can flourish and propagate. “There is this
pool of genes subject to selection pressure, with
the potential for further evolution.”
The hospital environment, where antibiotic
use is heaviest, has hosted the development of
staphylococcus that can inactivate the penicilli-
nase-resistant methicillin. And triclosan, an
antibacterial agent present in many household
items like deodorant, toothpaste and carpeting,
is not helping the situation. Triclosan’s ubiqui-
ty, Dr. Rankin said, will undoubtedly promote
the evolution of multi-drug-resistant organ-
isms. Though we try to keep up with their
progress, bacteria may always be one step
ahead of us, she said.
“We will never win. There is nothing we can
throw at them that they haven’t already
encountered in their 3.2 billion years on earth.”
—Joan Capuzzi Giresi, V’98
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